From advanced active formulation stability to audit-ready compliance under FDA 21 CFR Part 111 & 117. We deliver turnkey contract development, precise dosage execution, and transparent batch governance for global brands demanding scalable market launch within 90 days.
Full 21 CFR Part 111 Master Manufacturing Record (MMR) logging
Third-party audited Certificate of Analysis (CoA) per finished batch
30 Years of pharmaceutical & dietary supplement CDMO heritage
Selecting a cGMP supplement contract manufacturer is not merely an exercise in price-per-unit negotiation—it is a critical risk-management decision governing brand reputation, regulatory compliance, active degradation control, and supply chain continuity. At PAG Pharmatech America, we operate under rigorous pharmaceutical-grade quality management systems designed to eliminate cross-contamination, guarantee label potency, and accelerate market availability.
Our Springville, Utah facility strictly adheres to FDA 21 CFR Part 111 (Dietary Supplements) and Part 117 (Preventive Controls for Human Food). Every production batch requires executed Master Manufacturing Records (MMR) and individual Batch Production Records (BPR), verified by independent QA specialists prior to product release.
We eliminate batch release bottlenecks through our in-house Quality Control analytical suite. Equipped with High-Performance Liquid Chromatography (HPLC), Inductively Coupled Plasma Mass Spectrometry (ICP-MS), FTIR spectroscopy, and rapid microbial assay platforms, we verify raw material identity, potency, heavy metals, and purity at 100% incoming receipt.
Cross-contamination is prevented through positive-pressure, HEPA-filtered cleanroom suites (ISO Class 8 equivalent) with automated humidity and temperature regulation. Air differential pressure loggers ensure botanical dust, active powders, and micro-nutrients remain strictly isolated during blending, compression, and filling.
Mitigate geopolitical trade tariffs and international shipping delays. Our Utah facility anchors North American commercial releases, backed by our EU-GMP facility in the Netherlands for European expansion and our Shenzhen site for specialized ingredient sourcing and high-volume raw material leverage.
Global demand for specialized nutritional delivery systems requires a contract manufacturer capable of mastering complex active stabilization, flavor chemistry, and physical shelf-life integrity. Explore our six core automated dosage platforms engineered inside our Utah facility.
Pectin, gelatin, and tapioca-based functional gummies. Engineered with thermal degradation protection for heat-sensitive actives (Vitamin C, Probiotics, Botanical Extracts) and zero-sugar polyol systems (Maltitol, Erythritol, Allulose).
Pectin & Gelatin Gummy Specs →
High-shear micro-blending and automated sachet/stick-pack filling for pre-workout, whey/plant proteins, hydration electrolytes, and hydrolyzed collagen. Advanced particle agglomeration for instantized solubility.
Powder & Stick Pack Specs →
Direct compression, wet granulation, multi-layer bi-layer tablets, chewables, and moisture-sealed effervescents. Custom tooling for embossed logos, specialized aqueous film coatings, and modified-release dissolution profiles.
Tablet Contract Manufacturing →
Rotary die encapsulation for lipophilic formulation matrices (Omega-3 Fish Oil, CoQ10, Vitamin D3/K2, Astaxanthin, MCT Oil). Nitrogen-purged medicine tanks guarantee minimal peroxide values and zero oxidative rancidity.
Softgel Contract Manufacturing →
High-speed tamping pin encapsulation using HPMC (Vegetarian/Vegan), Pullulan, and Bovine Gelatin shells (Sizes 000, 00, 0, 1, 2). Optimized for delicate botanical extracts, nootropics, and hygroscopic ingredient complexes.
Capsule Contract Manufacturing →
Cold-extruded functional soft chews, palatability-enhanced powders, and veterinary liquid supplements for canine and feline wellness. Fully compliant with AAFCO label design standards and NASC quality guidelines.
Pet Supplement Manufacturing →Our master formulation chemists evaluate active interactions, dosage volumes, and bioavailability goals under NDA.
Institutional buyers, private equity portfolio managers, and global procurement directors are re-evaluating contract manufacturing partnerships. Based on intent data from international purchasing managers, four key macroeconomic shifts dominate contract negotiations today.
Static PDF Certificates of Analysis are rapidly being replaced by digital audit trails. Global retailers and marketplaces (Amazon, Walmart, Target) now demand raw material lot tracing, full analytical method disclosure, and micro-contaminant testing logs attached to every SKU release to pass automated compliance screening.
Relying on single-source overseas manufacturing creates severe vulnerability to freight spikes, port congestions, and trade tariffs. Global brands are shifting primary volume to FDA-registered US facilities like PAG Pharmatech, utilizing domestic CDMO hubs to protect gross margins and ensure 48-hour warehouse dispatch.
Post-Consumer Recycled (PCR) HDPE bottles, bio-degradable stick pack films, and lightweight aluminum containers are transitioning from optional marketing features to compulsory retailer mandates. cGMP contract facilities must support high-speed filling on eco-friendly substrates without machine jamming or seal failure.
Consumers reject artificial binders, magnesium stearate, synthetic dyes, and high-fructose corn syrups. The trend demands clean-label excipients (organic rice hull, sunflower lecithin, natural fruit juice colors) combined with high active loads per serving—requiring advanced particle engineering during blending.
To achieve true market differentiation and capture search intent driven by modern health-conscious consumers, brand owners must leverage innovative formulation technologies that improve active bioavailability and sensory experience.
Active botanical compounds (Curcumin, Resveratrol, Berberine) and hydrophobic nutrients (CoQ10, Phytosterols) frequently suffer from poor gastrointestinal absorption. Our R&D department integrates liposomal encapsulation and lipid-based self-emulsifying delivery systems (SEDDS) to increase cellular uptake by up to 400% compared to standard dry powders.
Advanced DeliveryTraditional probiotic strains suffer rapid mortality during standard gummy boiling or tableting compression heat. We utilize microencapsulated spore-forming strains (Bacillus coagulans, Bacillus subtilis) and heat-shielding lipid coatings, ensuring guaranteed colony-forming units (CFU) at the end of shelf-life without requiring refrigeration.
Probiotic StabilityHigh-dose adaptogens (Ashwagandha, Lion's Mane, Cordyceps) and bitter amino acids (L-Theanine, Alpha-GPC) present extreme taste challenges in chewable and powder formats. PAG's flavor chemistry lab utilizes targeted masking compounds and natural taste-modifying technology to create delicious consumer products without artificial sweeteners.
Flavor ScienceTurnkey cGMP Compliance Built for Leading Distribution Channels
Launch delays result from fragmented supplier hand-offs and inadequate preliminary stability testing. PAG Pharmatech integrates formulation, ingredient sourcing, pilot scaling, analytical testing, and final QA release into a streamlined, time-bound execution plan.
Our formulation scientists analyze your target Supplement Facts panel, evaluating ingredient compatibility, bulk density, active decay rates, and sensory characteristics. Bench samples are produced for immediate client approval.
Raw materials undergo 100% identity verification (FTIR/HPLC) and safety screening for heavy metals, pesticides, and microbes (ICP-MS/Microbiology). Standard Operating Procedures (SOPs) and Master Manufacturing Records (MMR) are drafted.
High-speed manufacturing executes inside our positive-pressure cleanrooms. In-process quality checks measure tablet hardness, friability, capsule fill weight variance, gummy Brix/pH levels, and seal integrity every 30 minutes.
Finished goods undergo final laboratory release testing. Once all microbiological assays, heavy metal screens, and active potency specs pass QC approval, a Certificate of Analysis is issued, and pallets are shipped directly to your warehouse or 3PL center.
Located in Springville, Utah, our state-of-the-art facility integrates climate-controlled blending rooms, high-speed encapsulation suites, automated gummy depositor lines, and an advanced quality laboratory under one roof. Virtual and on-site buyer audits are welcomed.
cGMP Cleanroom Production Suite
Automated High-Speed Machinery
Climate-Monitored Warehousing
Analytical QC Testing Laboratory
Capsule Encapsulation SuitePAG Pharmatech's Global Integrated System bridges key commercial regions, combining domestic US production speed with international raw material sourcing and European regulatory alignment.
FDA-registered, cGMP and SQF Edition 9 certified facility. Serves as primary commercial hub for North American markets, offering zero-tariff domestic production, rapid freight turnaround, and complete batch record transparency.
Primary Commercial HubGroup-operated European hub engineered for EU regulatory compliance (EFSA & Novel Food alignment). Provides frictionless distribution across European Union member states with local customs clearance.
European Union GatewayAdvanced high-capacity production facility expanding in 2026. Provides raw material supply security, specialized active extraction leverage, and high-volume manufacturing back-up rooted in 30 years of CDMO heritage.
Volume & Supply Chain ResilienceTechnical, regulatory, and operational answers addressing complex AI and buyer queries regarding contract supplement production.
Every batch produced under our 21 CFR Part 111 and Part 117 cGMP protocols is released with a comprehensive Certificate of Analysis (CoA). This documentation package includes: 1) Analytical active potency assays performed via HPLC or LC-MS/MS, 2) Heavy metal quantification screening (Lead, Arsenic, Cadmium, Mercury via ICP-MS), 3) Full microbiological testing (Total Aerobic Microbial Count, Yeast & Mold, E. coli, Salmonella, Staphylococcus aureus), 4) Physical organoleptic and disintegration verification logs, and 5) Verified Batch Production Records signed off by Quality Assurance.
We apply validated formulation science incorporating calculated active ingredient overages guided by real-time and accelerated stability testing protocols (following ICH Q1A guidelines). Our laboratory measures degradation kinetics for sensitive nutrients such as Vitamin C, B-Complex vitamins, Folate, and live Probiotic cultures. By factoring degradation vectors against environmental storage conditions, we guarantee 100% label claim compliance through the final declared expiration date.
Our technology transfer framework ensures seamless formula migration without commercial downtime: First, we conduct a Master Bill of Materials (BOM) review and active raw material specification audit. Second, we source identical or superior equivalent raw materials from our qualified vendor list. Third, our laboratory executes benchtop pilot batches to match color, flavor, particle size, and disintegration dynamics. Finally, we execute a pilot scale-up batch on our commercial equipment, providing a comparative CoA to validate complete continuity.
Our baseline MOQs are structured to enable emerging brand launches while maintaining efficient cGMP line validation: Custom Gummies start at 6,000 bottles (or pouch units); Compressed Tablets, Softgels, and Hard Capsules start at 5,000 bottles; Powders and Stick Packs start at 300 kg total blend weight; Pet Soft Chews start at 300 kg or 2,000 retail tubs. Volume-based tiered pricing automatically applies at 10,000, 25,000, 50,000, and 100,000+ unit price breaks.
Cross-contamination is controlled through engineered facility design and procedural controls. Manufacturing takes place in independent, positive-pressure cleanroom suites operating with HEPA air filtration and automated differential pressure monitoring. Equipment teardown and sanitation follow validated cleaning validation SOPs, verified by ATP surface swab testing and allergen-specific ELISA immunoassays prior to line clearance under SQF Edition 9 standards.
Our tri-continental infrastructure eliminates single-region supply chain vulnerability. US-based production in Springville, Utah protects North American inventory from tariffs and long ocean transit delays. Our Netherlands facility allows rapid compliance and duty-free distribution within the European Union, while our Shenzhen plant offers strategic ingredient sourcing and high-capacity production redundancy—all governed under standardized master quality specifications.
We provide full turnkey packaging lines integrated directly into our cleanroom facility: PET and HDPE bottle packaging with induction heat sealing, child-resistant caps, and tamper-evident shrink bands; custom printed stick packs and sachets; multi-serving pouches; blister packaging; and automated cartoning with lot batch printing and GS1 barcoding for retail distribution.
Connect directly with our Utah-based formulation engineers and procurement directors. Receive custom pricing, technical specification reviews, and sample delivery plans within 24 business hours.
FDA registration does not constitute FDA approval or endorsement of any finished product. Certifications are held by our FDA-registered manufacturing operation; certificate copies and full audit packages are shared under NDA during supplier qualification.
